(Iliadis et al., 1985; Favre et al., 1987). Moreover, sampling points are generally chosen arbitrarily or sometimes by using more sophisticated approaches like sensitivity functions or stepwise linear regression (Ratain & Vogelzang, 1987). But these approaches are not optimal, since they do not provide maximal precision in model parameters.Adriamycin (ADM) is a broad-spectrum antineoplastic drug which is active against a wide variety of tumours.Experimental studies have suggested that ADM concentration-time product (area under the curve, AUC) is a determinant factor for tumour cell lethality (Eichholtz-Wirth, 1980; Ritch et al., 1982 Included were 42% of patients with primary tumour only, 10% with primary and distal metastases, 38% with multifocal metastases and 10% with isolated metastases (liver and bone). There was no concomitant irradiation. Cumulative dose of ADM per patient was (mean, range) 372mg, 100-600 mg. Five patients had previously been treated by a chemotherapy regimen including anthracyclines and the total cumulative dose, including weekly ADM, was (mean, range) 640mg, 160-1,011mg; two other patients had received a chemotherapy protocol without anthracyclines. All patients had normal pretreatment serum bilirubin (5-17jmoll-1). In all cases, ADM was given by a 5-min infusion through a venous catheter. A complete pharmacokinetic study concerning ADM given on a weekly schedule on the same patients has been published (Frenay et al., 1988).Analttical method A complete pharmacokinetic profile was obtained for the first injection in 25 patients and once a month in 10 of them, i.e. in most cases at the 5th, 9th and 13th injections. Blood samples were drawn 5, 20, 40mmn and 1, 2. 4, 8 and 24h after the start of injection. As all patients were treated on an outpatient basis, it was not possible to get blood samples for more than the 24 h. From these patients and their cycles, 41 concentration-time curves were obtained. Blood samples were collected in EDTA tubes and immediately centrifuged.Plasma was stored at -20-C until analysis (within 2 weeks). ADM was quantified by HPLC. Extraction was performed on Sep-Pak C18 cartnrdges (Millipore, Waters) as previously described (Robert. 1980) with slight modifications: cartnrdges were conditioned by successive elutions with 2ml methanol and 5 ml phosphate buffer (Na2HPO4, 0.05 M; NaH2P04, 0.05 M; 2:1). One ml of plasma (patient or plasma for standard curve) spiked with 50 pi of internal standard (daunorubicin, 1 nmol ml -1) was passed through the cartridge, followed by I ml of phosphate buffer (discarded). Drug material was eluted by 3 ml of methanol in previously Br. J. Cancer O 989). 60, [89][90][91][92]
35 patients with refractory or relapsed acute leukemia received salvage chemotherapy using high‐dose cytosine arabinoside 2 g/m2 intravenously for 3 hours every 12 h, in 8 doses, followed by continuous infusion of mitoxantrone 12 mg/m2/day for 2 d. 9 patients had acute myeloblastic leukemia (AML), (4 relapsed, 5 refractory), 20 had acute lymphoblastic leukemia (ALL) (11 relapsed, 9 refractory) and 6 had chronic myelogenous leukemia (CML) in the blastic phase (BP). 4 out of 9 AML and 16 out of 20 ALL achieved complete remission. Median survival was 6 months for all patients and 10 months for responders. A short (1.5 months) chronic phase was achieved in 3 patients with CML. The main toxic effect was hematologic. A pharmacokinetic study was performed on mitoxantrone. No correlation was found with clinical response. The combination of mitoxantrone and ara‐C is an effective antileukemic regimen, especially in ALL.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.